91É«ÇéƬ

About 91É«ÇéƬ

91É«ÇéƬ GmbH is a medical technology start-up dedicated to offering innovative solutions that contribute both to optimized patient care as well as minimizing the complexity of surgical interventions. Since its founding in 2019, 91É«ÇéƬ has been developing SINEFIXâ„¢ to simplify rotator cuff tear surgery and improve patient outcomes. SINEFIX received FDA clearance in 2023.

SINEFIX is not approved for sale outside the U.S.

To learn more follow us on .